Contact Us
Your Health
Diseases & Conditions
Approved Medicines
TD Awareness
Investigational Therapies
Our Science
Approved Medicines
Pipeline
Clinical Studies
Our Company
About Us
Leadership
News & Media
Our Responsibility
DE&I
Funding & Support Requests Portal
Investors
Investor Overview
Stock Information
Financial Communications
News Releases
Corporate Governance
Sustainability
Business Development
Webcasts & Presentations
Careers
Meet Our People
Work with Us
Explore Our Benefits
Your Health
Diseases & Conditions
Approved Medicines
TD Awareness
Investigational Therapies
Our Science
Approved Medicines
Pipeline
Clinical Studies
Our Company
About Us
Leadership
News & Media
Our Responsibility
DE&I
Funding & Support Requests Portal
Investors
Investor Overview
Stock Information
Financial Communications
News Releases
Corporate Governance
Sustainability
Business Development
Webcasts & Presentations
Careers
Meet Our People
Work with Us
Explore Our Benefits
+
Investor Overview
Stock Information
Stock Quote
Shareholder Contacts
Analyst Coverage
Financial Communications
SEC Filings
Annual Meeting
Webcasts & Presentations
Online Annual Reports
News Releases
Corporate Governance
Sustainability
Business Development
Webcasts & Presentations
Annual Meeting
View Documents for the 2024 Annual Meeting of Shareholders
Close
This site uses cookies to ensure you get the best experience on our website.
Learn More
Accept
Close
You are leaving Neurocrine.com
< Go Back
Continue